Phase 4 Hepatitis B Virus Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Hepatitis B Virus (HBV)Lung Transplant Recipient
University Health Network, Toronto20 enrolled1 locationNCT07189377
Active
Phase 4
A randomized controlled trial to study whether telbivudine can prevent virus reactivation and improve the prognosis after liver resection in patients with hepatitis B virus-related hepatocellular carcinoma
hepatitis B virus-related hepatocellulcar carcinoma
ZHOU Wei-ping200 enrolled1 locationACTRN12614001224617
Recruiting
Phase 4
Asses the safety and efficacy of switching to tenofovir and lamivudine therapy in patients who have been receiving Hepatitis B Immunoglobulin and lamivudine prophylasix post liver transplant.
prevent Hepatitis B virus re-infection following liver transplantation with the use of tenofovir and lamivudine, withdrawing HBIG.
Professor Peter Angus40 enrolled1 locationACTRN12611001236987
Recruiting
Phase 4
The Extension Study
Chronic Hepatitis B Virus Infection
Prof. Meng Ngu, Concord Hospital28 enrolled1 locationACTRN12606000283572